Redox molecular machines involved in tumor progression

Antioxidants and Redox Signaling

Volumn 19, Issue 15, 2013, Pages 1828-1845

  Parri, Matteo ^a   Chiarugi, Paola ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Istituto Toscano Tumori   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADENYLATE MONOPHOSPHATE KINASE; ANTINEOPLASTIC AGENT; ATM PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BETA ACTIN; BIOLOGICAL MARKER; GA BINDING PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PENTOSE PHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; PYRUVATE KINASE; PYRUVATE KINASE M2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL CONTACT; CELL FUNCTION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; DNA REPAIR; ENZYME GLYCOSYLATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GLYCOLYSIS; HUMAN; LIPID PEROXIDATION; METABOLIC REGULATION; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL ADHESION; CYTOSKELETON; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; OXIDATION-REDUCTION;

EID: 84887621539     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5040     Document Type: Review

References (144)

1. Akhand AA, Pu M, Senga T., Kato M, Suzuki H, Miyata T., Hamaguchi M, and Nakashima I. Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem 274: 25821-25826, 1999.
2. Amente S, Bertoni A, Morano A., Lania L, Avvedimento EV, and Majello B. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 29: 3691-3702, 2010.
3. Anastasiou D, Poulogiannis G, Asara J.M., Boxer MB, Jiang JK, Shen M, Bellinger G., Sasaki AT, Locasale JW, Auld DS, Thomas C.J., Vander Heiden MG, and Cantley LC. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334: 1278-1283, 2011.
4. Barnes PJ, Ito K, and Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363: 731-733, 2004. (Pubitemid 38296564)
5. Bloom D, Dhakshinamoorthy S, and Jaiswal AK. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductase1 gene. Oncogene 21: 2191-2200, 2002. (Pubitemid 34311373)
6. Boivin B, Yang M, and Tonks NK. Targeting the reversibly oxidized protein tyrosine phosphatase superfamily. Sci Signal 3: 12, 2010.
7. Brunet A, Bonni A, Zigmond M.J., Lin MZ, Juo P, Hu LS, Anderson M.J., Arden KC, Blenis J, and Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857-868, 1999. (Pubitemid 29165088)
8. Buricchi F, Giannoni E, Grimaldi G., Parri M, Raugei G, Ramponi G., and Chiarugi P. Redox regulation of ephrin/integrin cross-talk. Cell Adh Migr 1: 33-42, 2007.
9. Butterfield DA, Hardas SS, and Lange ML. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. J Alzheimers Dis 20: 369-393, 2010.
10. Cannito S, Novo E, di Bonzo LV, Busletta C, Colombatto S, and Parola M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal 12: 1383-1430, 2010.
11. Cao J, Schulte J, Knight A., Leslie NR, Zagozdzon A, Bronson R, Manevich Y., Beeson C, and Neumann CA. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J 28: 1505-1517, 2009.
12. Cardaci S, Filomeni G, and Ciriolo MR. Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci 125: 2115-2125, 2012.
13. Chandel NS. Mitochondrial regulation of oxygen sensing. Adv Exp Med Biol 661: 339-354, 2010.
14. Chiang AC and Massague J. Molecular basis of metastasis. N Engl J Med 359: 2814-2823, 2008.
15. Chiarugi P. From anchorage dependent proliferation to survival: lessons from redox signalling. IUBMB Life 60: 301-307, 2008.
16. Chiarugi P and Buricchi F. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid Redox Signal 9: 1-24, 2007. (Pubitemid 44910992)
17. Chiarugi P, Cirri P, Taddei L., Giannoni E, Camici G, Manao G., Raugei G, and Ramponi G. The low M(r) proteintyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem 275: 4640-4646, 2000. (Pubitemid 30108849)
18. Chiarugi P, Fiaschi T, Taddei M.L., Talini D., Giannoni E, Raugei G, and Ramponi G. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276: 33478-33487, 2001.
19. Chiarugi P and Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364, 2008.
20. Chiarugi P, Pani G, Giannoni E., Taddei L, Colavitti R, Raugei G., Symons M, Borrello S, Galeotti T., and Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161: 933-944, 2003. (Pubitemid 36718426)
21. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming M.D., Schreiber SL, and Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233, 2008. (Pubitemid 351380249)
22. Cobbs CS, Samanta M, Harkins L.E., Gillespie GY, Merrick BA, and MacMillan-Crow LA. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch Biochem Biophys 394: 167-172, 2001. (Pubitemid 32989325)
23. Comito G, Calvani M, Giannoni E., Bianchini F, Calorini L, Torre E., Migliore C, Giordano S, and Chiarugi P. HIF-1alpha stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med 51: 893-904, 2011.
24. Comito G, Giannoni E, Gennaro P.D., Segura CP, Gerlini G, and Chiarugi P. Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett 324: 31-41, 2012.
25. Comoglio PM, Boccaccio C, and Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 15: 565-571, 2003. (Pubitemid 37176965)
26. Cosentino C, Grieco D, and Costanzo V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30: 546-555, 2011.
27. Culhane JC and Cole PA. LSD1 and the chemistry of his-tone demethylation. Curr Opin Chem Biol 11: 561-568, 2007.
28. Dansen TB, Smits LM, van Triest MH, de Keizer PL, van LD, Koerkamp MG, Szypowska A, Meppelink A., Brenkman AB, Yodoi J, Holstege FC, and Burgering BM. Redoxsensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat Chem Biol 5: 664-672, 2009.
29. de Keizer P.L., Burgering BM, and Dansen TB. Forkhead box o as a sensor, mediator, and regulator of redox signaling. Antioxid Redox Signal 14: 1093-1106, 2011.
30. Dinkova-Kostova A.T., Holtzclaw WD, Cole R.N., Itoh K., Wakabayashi N, Katoh Y, Yamamoto M., and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99: 11908-11913, 2002. (Pubitemid 34994497)
31. Duffy MJ, McGowan PM, and Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol 214: 283-293, 2008. (Pubitemid 351212383)
32. Emerling BM, Weinberg F, Snyder C., Burgess Z, Mutlu GM, Viollet B, Budinger G.R., and Chandel NS. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med 46: 1386-1391, 2009.
33. Erez N, Truitt M, Olson P., Arron ST, and Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17: 135-147, 2010.
34. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, and Burgering BM. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23: 4802-4812, 2004. (Pubitemid 40069710)
35. Etienne-Manneville S and Hall A. Rho GTPases in cell biology. Nature 420: 629-635, 2002. (Pubitemid 36764489)
36. Farah ME and Amberg DC. Conserved actin cysteine residues are oxidative stress sensors that can regulate cell death in yeast. Mol Biol Cell 18: 1359-1365, 2007. (Pubitemid 46626630)
37. Fiaschi T and Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. Int J Cell Biol 2012: 762825, 2012.
38. Fiaschi T, Cozzi G, and Chiarugi P. Redox regulation of nonmuscle myosin heavy chain during integrin engagement. J Signal Transduct 2012: 754964, 2012.
39. Fiaschi T, Cozzi G, Raugei G., Formigli L, Ramponi G, and Chiarugi P. Redox regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem 281: 22983-22991, 2006.
40. Filomeni G, Desideri E, Cardaci S., Graziani I, Piccirillo S, Rotilio G., and Ciriolo MR. Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy 6: 202-216, 2010.
41. Fratelli M, Demol H, Puype M., Casagrande S, Eberini I, Salmona M., Bonetto V, Mengozzi M, Duffieux F., Miclet E, Bachi A, Vandekerckhove J, Gianazza E, and Ghezzi P. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 99: 3505-3510, 2002. (Pubitemid 34252138)
42. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 16: 14-23, 2004. (Pubitemid 38368147)
43. Gao P, Zhang H, Dinavahi R., Li F, Xiang Y, Raman V., Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J., Lee LA, Semenza GL, and Dang CV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12: 230-238, 2007. (Pubitemid 47333417)
44. Gerald D, Berra E, Frapart Y.M., Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J., Yaniv M, and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118: 781-794, 2004. (Pubitemid 39221736)
45. Giannoni E, Bianchini F, Calorini L., and Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a pro-inflammatory signature leading to EMT and stemness. Antioxid Redox Signal 14: 2361-2371, 2011.
46. Giannoni E, Bianchini F, Masieri L., Serni S, Torre E, Calorini L., and Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70: 6945-6956, 2010.
47. Giannoni E, Buricchi F, Grimaldi G., Parri M, Cialdai F, Taddei M.L., Raugei G., Ramponi G, and Chiarugi P. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ 15: 867-878, 2008. (Pubitemid 351524429)
48. Giannoni E, Buricchi F, Raugei G., Ramponi G, and Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25: 6391-6403, 2005. (Pubitemid 41023216)
49. Giannoni E, Fiaschi T, Ramponi G., and Chiarugi P. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28: 2074-2086, 2009.
50. Giannoni E, Parri M, and Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid Redox Signal 16: 1248-1263, 2012.
51. Giannoni E, Taddei ML, and Chiarugi P. Src redox regulation: again in the front line. Free Radic Biol Med 49: 516-527, 2010.
52. Gloire G and Piette J. Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal 11: 2209-2222, 2009.
53. Grant CM, Quinn KA, and Dawes IW. Differential protein S-thiolation of glyceraldehyde-3-phosphate dehydrogenase isoenzymes influences sensitivity to oxidative stress. Mol Cell Biol 19: 2650-2656, 1999. (Pubitemid 29144509)
54. Gruning NM, Lehrach H, and Ralser M. Regulatory crosstalk of the metabolic network. Trends Biochem Sci 35: 220-227, 2010.
55. Gruning NM and Ralser M. Cancer: Sacrifice for survival. Nature 480: 190-191, 2011.
56. Gruning NM, Rinnerthaler M, Bluemlein K., Mulleder M, Wamelink MM, Lehrach H, Jakobs C., Breitenbach M, and Ralser M. Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells. Cell Metab 14: 415-427, 2011.
57. Gu Z, Kaul M, Yan B., Kridel SJ, Cui J, Strongin A, Smith J.W., Liddington RC, and Lipton SA. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186-1190, 2002. (Pubitemid 36193354)
58. Gueraud F, Atalay M, Bresgen N., Cipak A, Eckl PM, Huc L, Jouanin I., Siems W, and Uchida K. Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44: 1098-1124, 2010.
59. Guo Z, Kozlov S, Lavin M.F., Person MD, and Paull TT. ATM activation by oxidative stress. Science 330: 517-521, 2010.
60. Guzy RD, Hoyos B, Robin E., Chen H, Liu L, Mansfield K.D., Simon MC, Hammerling U, and Schumacker PT. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1: 401-408, 2005. (Pubitemid 43960623)
61. Hadad SM, Baker L, Quinlan P.R., Robertson KE, Bray SE, Thomson G, Kellock D., Jordan LB, Purdie CA, Hardie DG, Fleming S, and Thompson AM. Histological evaluation of AMPK signalling in primary breast cancer. BMC Cancer 9: 307, 2009.
62. Haddad JJ and Land SC. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett 505: 269-274, 2001. (Pubitemid 32896679)
63. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
64. Hardie DG. Biochemistry. Balancing cellular energy. Science 315: 1671-1672, 2007.
65. Harhaji-Trajkovic L., Vilimanovich U, Kravic-Stevovic T, Bumbasirevic V., and Trajkovic V. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J Cell Mol Med 13: 3644-3654, 2009.
66. Hayes JD and McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34: 176-188, 2009.
67. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 55: 735-750, 1999. (Pubitemid 29257624)
68. Herscovitch M, Comb W, Ennis T., Coleman K, Yong S, Armstead B., Kalaitzidis D, Chandani S, and Gilmore TD. Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347. Biochem Biophys Res Commun 367: 103-108, 2008.
69. Hou H and Yu H. Structural insights into histone lysine demethylation. Curr Opin Struct Biol 20: 739-748, 2010.
70. Hurley PJ and Bunz F. ATM and ATR: components of an integrated circuit. Cell Cycle 6: 414-417, 2007. (Pubitemid 46393443)
71. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta 1784: 56-65, 2008.
72. Itoh K, Wakabayashi N, Katoh Y., Ishii T, Igarashi K, Engel J.D., and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86, 1999. (Pubitemid 29045117)
73. Jamaluddin M, Wang S, Boldogh I., Tian B, and Brasier AR. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19: 1419-1433, 2007. (Pubitemid 46818908)
74. Jenkins JL and Tanner JJ. High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr 62: 290-301, 2006. (Pubitemid 44185138)
75. Jiang P, Du W, Wang X., Mancuso A, Gao X, Wu M., and Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 13: 310-316, 2011.
76. Kabe Y, Ando K, Hirao S., Yoshida M, and Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403, 2005. (Pubitemid 40279807)
77. Kaelin WG Jr. and Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30: 393-402, 2008. (Pubitemid 351681994)
78. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119: 1417-1419, 2009.
79. Kim DH, Kundu JK, and Surh YJ. Redox modulation of p53: mechanisms and functional significance. Mol Carcinog 50: 222-234, 2011.
80. Kim I, Han SJ, Kim Y, Ahn Y., Chay KO, and Lee SR. Tyr740 and Tyr751 residues of platelet-derived growth factor beta receptor are responsible for the redox regulation of phosphatase and tensin homolog in the cells stimulated with platelet-derived growth factor. Redox Rep 16: 181-186, 2011.
81. Kruger A, Gruning NM, Wamelink M.M., Kerick M., Kirpy A, Parkhomchuk D, Bluemlein K., Schweiger MR, Soldatov A, Lehrach H, Jakobs C., and Ralser M. The pentose phosphate pathway is a metabolic redox sensor and regulates transcription during the antioxidant response. Antioxid Redox Signal 15: 311-324, 2011.
82. Landriscina M, Maddalena F, Laudiero G., and Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 11: 2701-2716, 2009.
83. Langbein S, Frederiks WM, zur H.A., Popa J., Lehmann J, Weiss C, Alken P., and Coy JF. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer 122: 2422-2428, 2008. (Pubitemid 351590473)
84. Lehtinen MK, Yuan Z, Boag P.R., Yang Y., Villen J, Becker EB, Di Bacco S, de la Iglesia N, Gygi S, Blackwell TK, and Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001, 2006. (Pubitemid 43795191)
85. Leslie NR, Batty IH, Maccario H, Davidson L., and Downes CP. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27: 5464-5476, 2008.
86. Leslie NR, Bennett D, Lindsay Y.E., Stewart H., Gray A, and Downes CP. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22: 5501-5510, 2003. (Pubitemid 37279959)
87. Leu TH, Su SL, Chuang Y.C., and Maa MC. Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem Pharmacol 66: 2323-2331, 2003. (Pubitemid 37456740)
88. Lin T, Ponn A, Hu X., Law BK, and Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29: 4896-4904, 2010.
89. Liu B, Chen Y, and St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 44: 1529-1535, 2008.
90. Liu H, Colavitti R, Rovira I.I., and Finkel T. Redox-dependent transcriptional regulation. Circ Res 97: 967-974, 2005. (Pubitemid 41668909)
91. Lluis JM, Buricchi F, Chiarugi P., Morales A, and Fernandez-Checa JC. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res 67: 7368-7377, 2007. (Pubitemid 47206567)
92. Lv L, Li D, Zhao D., Lin R, Chu Y, Zhang H., Zha Z, Liu Y, Li Z., Xu Y, Wang G, Huang Y, Xiong Y, Guan KL, and Lei QY. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 42: 719-730, 2011.
93. Maillet A and Pervaiz S. Redox regulation of p53, redox effectors regulated by p53: a subtle balance. Antioxid Redox Signal 16: 1285-1294, 2012.
94. Mannick JB, Hausladen A, Liu L., Hess DT, Zeng M, Miao QX, Kane L.S., Gow AJ, and Stamler JS. Fas-induced caspase denitrosylation. Science 284: 651-654, 1999. (Pubitemid 29289591)
95. Masson N and Ratcliffe PJ. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci 116: 3041-3049, 2003. (Pubitemid 37038953)
96. Matthews JR, Kaszubska W, Turcatti G., Wells TN, and Hay RT. Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res 21: 1727-1734, 1993. (Pubitemid 23178885)
97. Melvin A and Rocha S. Chromatin as an oxygen sensor and active player in the hypoxia response. Cell Signal 24: 35-43, 2012.
98. Minetti M, Mallozzi C, and Di Stasi AM. Peroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic Biol Med 33: 744-754, 2002. (Pubitemid 35232310)
99. Myatt SS, Brosens JJ, and Lam EW. Sense and sensitivity: FOXO and ROS in cancer development and treatment. Antioxid Redox Signal 14: 675-687, 2011.
100. Nguyen DX, Bos PD, and Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284, 2009.
101. Nott A, Watson PM, Robinson J.D., Crepaldi L., and Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455: 411-415, 2008.
102. Oliveira-Marques V., Marinho HS, Cyrne L, and Antunes F. Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid Redox Signal 11: 2223-2243, 2009.
103. Pani G, Galeotti T, and Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29: 351-378, 2010.
104. Pani G, Giannoni E, Galeotti T., and Chiarugi P. Redox-based escape mechanism from death: the cancer lesson. Antioxid Redox Signal 11: 2791-2806, 2009.
105. Paravicini TM and Touyz RM. Redox signaling in hypertension. Cardiovasc Res 71: 247-258, 2006.
106. Patten DA, Lafleur VN, Robitaille G.A., Chan DA, Giaccia AJ, and Richard DE. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell 21: 3247-3257, 2010.
107. Perillo B, Ombra MN, Bertoni A, Cuozzo C., Sacchetti S, Sasso A, Chiariotti L., Malorni A, Abbondanza C, and Avvedimento EV. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319: 202-206, 2008.
108. Pineda-Molina E., Klatt P, Vazquez J., Marina A, Garcia de Lacoba M, Perez-Sala D, and Lamas S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40: 14134-14142, 2001. (Pubitemid 33081616)
109. Poels J, Spasic MR, Callaerts P, and Norga KK. Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. Bioessays 31: 944-952, 2009.
110. Polimeni M, Voena C, Kopecka J., Riganti C, Pescarmona G, Bosia A., and Ghigo D. Modulation of doxorubicin resistance by the glucose-6-phosphate dehydrogenase activity. Biochem J 439: 141-149, 2011.
111. Pyne NJ and Pyne S. Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow? Trends Pharmacol Sci 32: 443-450, 2011.
112. Ralser M, Wamelink MM, Kowald A, Gerisch B., Heeren G, Struys EA, Klipp E, Jakobs C., Breitenbach M, Lehrach H, and Krobitsch S. Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol 6: 10, 2007.
113. Ray PD, Huang BW, and Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981-990, 2012.
114. Rhee SG, Bae YS, Lee S.R., and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: e1, 2000.
115. Riganti C, Gazzano E, Polimeni M., Aldieri E, and Ghigo D. The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic Biol Med 53: 421-436, 2012.
116. Roos G and Messens J. Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radic Biol Med 51: 314-326, 2011.
117. Russo T, Zambrano N, Esposito F., Ammendola R, Cimino F, Fiscella M., Jackman J, O'Connor PM, Anderson CW, and Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270: 29386-29391, 1995.
118. Sandin A, Dagnell M, Gonon A., Pernow J, Stangl V, Aspenstrom P., Kappert K, and Ostman A. Hypoxia followed by re-oxygenation induces oxidation of tyrosine phosphatases. Cell Signal 23: 820-826, 2011.
119. Schroedl C, McClintock DS, Budinger G.R., and Chandel NS. Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283: L922-L931, 2002. (Pubitemid 35204884)
120. Semenza GL. Hypoxia. Cross talk between oxygen sensing and the cell cycle machinery. Am J Physiol Cell Physiol 301: C550-C552, 2011.
121. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33: 207-214, 2012.
122. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155-168, 2003. (Pubitemid 37328868)
123. Silva A, Yunes JA, Cardoso B.A., Martins LR, Jotta PY, Abecasis M, Nowill A.E., Leslie NR, Cardoso AA, and Barata JT. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 118: 3762-3774, 2008.
124. Staal FJ, Roederer M, Herzenberg L.A., and Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 87: 9943-9947, 1990. (Pubitemid 120016560)
125. Taddei ML, Giannoni E, Fiaschi T., and Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol 226: 380-393, 2012.
126. Taddei ML, Parri M, Mello T., Catalano A, Levine AD, Raugei G, Ramponi G., and Chiarugi P. Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. Antioxid Redox Signal 9: 469-481, 2007.
127. Taguchi K, Motohashi H, and Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123-140, 2011.
128. Tamada M, Nagano O, Tateyama S., Ohmura M, Yae T, Ishimoto T., Sugihara E, Onishi N, Yamamoto T., Yanagawa H, Suematsu M, and Saya H. Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Res 72: 1438-1448, 2012.
129. ten FH, Dagnell M, Leuchs M., Vantler M, Berghausen EM, Caglayan E, Weissmann N., Dahal BK, Schermuly RT, Ostman A, Kappert K., and Rosenkranz S. Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. Am J Respir Crit Care Med 183: 1092-1102, 2011.
130. Toullec A, Gerald D, Despouy G., Bourachot B, Cardon M, Lefort S., Richardson M, Rigaill G, Parrini M.C., Lucchesi C., Bellanger D, Stern MH, Dubois T, Sastre-Garau X, Delattre O, Vincent-Salomon A, and Mechta-Grigoriou F. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2: 211-230, 2010.
131. van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, and Burgering BM. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 279: 28873-28879, 2004. (Pubitemid 38915754)
132. Vander Heiden M.G., Cantley LC, and Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009.
133. Vander Heiden M.G., Locasale JW, Swanson K.D., Sharfi H., Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz J.D., Asara JM, and Cantley LC. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-1499, 2010.
134. Velu CS, Niture SK, Doneanu C.E., Pattabiraman N., and Srivenugopal KS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46: 7765-7780, 2007. (Pubitemid 47016060)
135. Villeneuve NF, Lau A, and Zhang DD. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal 13: 1699-1712, 2010.
136. Vurusaner B, Poli G, and Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med 52: 7-18, 2012.
137. Wang FS, Wang CJ, Chen Y.J., Chang PR, Huang YT, Sun YC, Huang H.C., Yang YJ, and Yang KD. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF - A expression in shock wave-stimulated osteoblasts. J Biol Chem 279: 10331-10337, 2004. (Pubitemid 38372640)
138. Ward PS and Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21: 297-308, 2012.
139. Wu Y, Deng J, Rychahou P.G., Qiu S., Evers BM, and Zhou BP. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15: 416-428, 2009.
140. Xanthoudakis S and Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665, 1992.
141. Yasinska IM and Sumbayev VV. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett 549: 105-109, 2003. (Pubitemid 36959853)
142. Ying H, Kimmelman AC, Lyssiotis C.A., Hua S., Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H., Coloff JL, Yan H, Wang W, Chen S., Viale A, Zheng H, Paik JH, Lim C, Guimaraes AR, Martin ES, Chang J, Hezel AF, Perry SR, Hu J, Gan B, Xiao Y, Asara JM, Weissleder R, Wang YA, Chin L, Cantley LC, and De Pinho RA. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149: 656-670, 2012.
143. Zhang DD and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151, 2003. (Pubitemid 37377505)
144. Zmijewski JW, Banerjee S, Bae H., Friggeri A, Lazarowski ER, and Abraham E. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem 285: 33154-33164, 2010.